메뉴 건너뛰기




Volumn 35, Issue 4, 2015, Pages 442-446

Concurrent Oral Antipsychotic Drug Use among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge

Author keywords

adherence; antipsychotic medication; long acting injectable; polypharmacy; schizophrenia

Indexed keywords

FLUPHENAZINE DECANOATE; HALOPERIDOL DECANOATE; LONG ACTING DRUG; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; DELAYED RELEASE FORMULATION;

EID: 84936953434     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000353     Document Type: Article
Times cited : (33)

References (17)
  • 1
    • 25444513417 scopus 로고    scopus 로고
    • Atypical antipsychotics and the burden of disease
    • Simpson GM. Atypical antipsychotics and the burden of disease. Am J Manag Care. 2005;1(suppl 8):S235-S241.
    • (2005) Am J Manag Care , vol.1 , pp. S235-S241
    • Simpson, G.M.1
  • 2
    • 0032965694 scopus 로고    scopus 로고
    • The economic impact of schizophrenia
    • 28-30
    • Rice DP. The economic impact of schizophrenia. J Clin Psychiatry. 1999; 60(suppl 1):4-6; 28-30.
    • (1999) J Clin Psychiatry , vol.60 , pp. 4-6
    • Rice, D.P.1
  • 3
    • 26644472427 scopus 로고    scopus 로고
    • The economic burden of schizophrenia in the United States in 2002
    • Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry. 2005;66:1122-1129.
    • (2005) J Clin Psychiatry , vol.66 , pp. 1122-1129
    • Wu, E.Q.1    Birnbaum, H.G.2    Shi, L.3
  • 4
    • 3042529588 scopus 로고    scopus 로고
    • Focus on antipsychotic polypharmacy: Evidence-based prescribing or prescribing-based evidence?
    • Stahl SM. Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence? Int J Neuropsychopharmacol. 2004;7:113-116.
    • (2004) Int J Neuropsychopharmacol , vol.7 , pp. 113-116
    • Stahl, S.M.1
  • 5
    • 14744291781 scopus 로고    scopus 로고
    • Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice
    • West JC, Wilk JE, Olfson M, et al. Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice. Psychiatr Serv. 2005;56:283-291.
    • (2005) Psychiatr Serv , vol.56 , pp. 283-291
    • West, J.C.1    Wilk, J.E.2    Olfson, M.3
  • 6
    • 12944304694 scopus 로고    scopus 로고
    • Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000
    • Ganguly R, Kotzan JA, Miller LS, et al. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000. J Clin Psychiatry. 2004;65:1377-1388.
    • (2004) J Clin Psychiatry , vol.65 , pp. 1377-1388
    • Ganguly, R.1    Kotzan, J.A.2    Miller, L.S.3
  • 7
    • 0242643663 scopus 로고    scopus 로고
    • Benchmarking the quality of schizophrenia pharmacotherapy: A comparison of the Department of Veterans Affairs and the private sector
    • Leslie DL, Rosenheck RA. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector. J Ment Health Policy Econ. 2003;6:113-121.
    • (2003) J Ment Health Policy Econ , vol.6 , pp. 113-121
    • Leslie, D.L.1    Rosenheck, R.A.2
  • 8
    • 0035988515 scopus 로고    scopus 로고
    • Antipsychotic prescribing practices in the Veterans Healthcare Administration-New York metropolitan region
    • Weissman EM. Antipsychotic prescribing practices in the Veterans Healthcare Administration-New York metropolitan region. Schizophr Bull. 2002;28:31-42.
    • (2002) Schizophr Bull , vol.28 , pp. 31-42
    • Weissman, E.M.1
  • 9
    • 84861087821 scopus 로고    scopus 로고
    • Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications
    • Aggarwal NK, Sernyak MJ, Rosenheck RA. Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications. J Clin Psychopharmacol. 2012; 32:323-328.
    • (2012) J Clin Psychopharmacol , vol.32 , pp. 323-328
    • Aggarwal, N.K.1    Sernyak, M.J.2    Rosenheck, R.A.3
  • 10
    • 34247367267 scopus 로고    scopus 로고
    • Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia
    • Shi L, Ascher-Svanum H, Zhu B, et al. Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia. Psychiatr Serv. 2007;58:482-488.
    • (2007) Psychiatr Serv , vol.58 , pp. 482-488
    • Shi, L.1    Ascher-Svanum, H.2    Zhu, B.3
  • 11
    • 33750039955 scopus 로고    scopus 로고
    • Annual prevalence of diagnosed schizophrenia in the USA: A claims data analysis approach
    • Wu EQ, Shi L, Birnbaum H, et al. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychol Med. 2006;36:1535-1540.
    • (2006) Psychol Med , vol.36 , pp. 1535-1540
    • Wu, E.Q.1    Shi, L.2    Birnbaum, H.3
  • 12
    • 33846468943 scopus 로고    scopus 로고
    • A checklist for medication compliance and persistence studies using retrospective databases
    • Peterson A, Nau D, Cramer J, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10:3-12.
    • (2007) Value Health , vol.10 , pp. 3-12
    • Peterson, A.1    Nau, D.2    Cramer, J.3
  • 13
    • 55349139334 scopus 로고    scopus 로고
    • When is antipsychotic polypharmacy supported by research evidence? Implications for QI
    • Gören JL, Parks JJ, Ghinassi FA, et al. When is antipsychotic polypharmacy supported by research evidence? Implications for QI. Jt Comm J Qual Patient Saf. 2008;34:571-582.
    • (2008) Jt Comm J Qual Patient Saf , vol.34 , pp. 571-582
    • Gören, J.L.1    Parks, J.J.2    Ghinassi, F.A.3
  • 15
    • 11244278062 scopus 로고    scopus 로고
    • Challenges to evidence-based medicine: A comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network
    • Zarin DA, Young JL, West JC. Challenges to evidence-based medicine: a comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network. Soc Psychiatry Psychiatr Epidemiol. 2005;40:27-35.
    • (2005) Soc Psychiatry Psychiatr Epidemiol , vol.40 , pp. 27-35
    • Zarin, D.A.1    Young, J.L.2    West, J.C.3
  • 16
    • 1642283731 scopus 로고    scopus 로고
    • Practice guideline for the treatment of patients with schizophrenia, second edition
    • Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(suppl 2):1-56.
    • (2004) Am J Psychiatry , vol.161 , pp. 1-56
    • Lehman, A.F.1    Lieberman, J.A.2    Dixon, L.B.3
  • 17
    • 1542270909 scopus 로고    scopus 로고
    • The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003
    • Lehman AF, Kreyenbuhl J, Buchanan RW, et al. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophr Bull. 2004;30:193-217.
    • (2004) Schizophr Bull , vol.30 , pp. 193-217
    • Lehman, A.F.1    Kreyenbuhl, J.2    Buchanan, R.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.